Login / Signup

Personalized Risk Communication and Opioid Prescribing In Association With Non-Prescribed Opioid Use: A Secondary Analysis of a Randomized Controlled Trial.

Max Jordan Nguemeni TiakoFrances ShoferAbby DolanErica B GoldbergKarin V RhodesErik P HessVenkatesh R BellamkondaJeanmarie PerroneCarolyn C CannuscioLance BeckerMelissa A RodgersMichael M ZylaJeffrey J BellSharon McCollumEden Engel-RebitzerMarilyn M SchapiraZachary F Meisel
Published in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2023)
Among Black but not White participants, personalized opioid risk communication and opioid prescribing were associated with lower odds of nonprescribed opioid use. Our findings suggest that racial disparities in opioid prescribing - which have been previously described within the context of this trial -- may paradoxically increase non-prescribed opioid use. Personalized risk communication may effectively reduce nonprescribed opioid use, and future research should be designed specifically to explore this possibility in a larger cohort.
Keyphrases
  • chronic pain
  • pain management
  • primary care
  • clinical trial
  • healthcare
  • study protocol
  • emergency department
  • randomized controlled trial
  • african american
  • drug induced
  • double blind
  • breast cancer risk
  • placebo controlled